Novo Nordisk | NVO - UTANG

Harga Saham
37.63
Perubahan Harian
0.72 1.95%
Bulanan
-5.38%
Tahunan
-42.22%
Q2 Perkiraan
35.05




UTANG Perubahan Tanggal
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bausch Health Companies USD 21.04B 696M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.36M 247K 2025-09
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Merck USD 41.37B 5.97B 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 32.64B 1.37B 2025-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Novo Nordisk DKK 118.72B 15.94B 2025-03
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Zoetis USD 7.27B 482M 2025-09